Structural and functional analysis of J chain-deficient IgM
- PMID: 9637512
Structural and functional analysis of J chain-deficient IgM
Abstract
Previous studies have discerned two forms of polymeric mouse IgM: moderately cytolytic (complement-activating) pentamer, which contains J chain, and highly cytolytic hexamer, which lacks J chain. To investigate the relationships among polymeric structure, J chain content, and cytolytic activity, we produced IgM in J chain-deficient and J chain-proficient mouse hybridoma cell lines. Both hexamer and pentamer were produced in the absence as well as the presence of J chain. Hexameric IgM activated (guinea pig) complement approximately 100-fold more efficiently than did J chain-deficient pentamer, which, in turn, was more active than J chain-containing pentamer. These results are consistent with the hypothesis that J chain-containing pentamer cannot activate complement. We also analyzed the structure of IgM-S337, in which the mu-chain bears the C337S substitution. Like normal IgM, IgM-S337 was formed as a hexamer and as both J chain deficient- and J chain-containing pentamers. Unlike normal IgM, IgM-S337 dissociated in SDS into various subunits. For IgM-S337 pentamer, the predominant subunits migrated as mu2kappa2 and mu4kappa4, and the subunit distribution was unaltered by J chain. However, J chain was found only in the mu2kappa2 species, suggesting that some arrangement of inter-mu bonds directs incorporation of J chain. IgM-S337 hexamer also dissociated to mu2kappa2 and mu4kappa4, but also yielded several species migrating much more slowly in SDS-PAGE than wild-type mu12kappa12. To account for these forms, we propose that each mu-chain can interact with three other mu-chains and that some hexameric molecules contain two catenated mu6kappa6 circles.
Similar articles
-
Differential activation of human and guinea pig complement by pentameric and hexameric IgM.Eur J Immunol. 2002 Jun;32(6):1802-10. doi: 10.1002/1521-4141(200206)32:6<1802::AID-IMMU1802>3.0.CO;2-C. Eur J Immunol. 2002. PMID: 12115664
-
On the structure of polymeric IgM.Eur J Immunol. 1988 Jul;18(7):1001-8. doi: 10.1002/eji.1830180705. Eur J Immunol. 1988. PMID: 3136022
-
Analysis of IgM structures involved in J chain incorporation.J Immunol. 1997 Feb 15;158(4):1719-26. J Immunol. 1997. PMID: 9029108
-
[Problem of J-chain of immunoglobulins].Zh Evol Biokhim Fiziol. 2008 Mar-Apr;44(2):131-43. Zh Evol Biokhim Fiziol. 2008. PMID: 18669274 Review. Russian.
-
The coming of age of the immunoglobulin J chain.Annu Rev Immunol. 1985;3:425-53. doi: 10.1146/annurev.iy.03.040185.002233. Annu Rev Immunol. 1985. PMID: 2415140 Review.
Cited by
-
The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein.Sci Adv. 2018 Oct 10;4(10):eaau1199. doi: 10.1126/sciadv.aau1199. eCollection 2018 Oct. Sci Adv. 2018. PMID: 30324136 Free PMC article.
-
Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.Immunol Res. 2011 Oct;51(1):97-107. doi: 10.1007/s12026-011-8236-8. Immunol Res. 2011. PMID: 21786026
-
Glycosylation of Plant-Produced Immunoglobulins.Exp Suppl. 2021;112:519-543. doi: 10.1007/978-3-030-76912-3_16. Exp Suppl. 2021. PMID: 34687021
-
Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles.Antib Ther. 2020 Apr 18;3(2):71-79. doi: 10.1093/abt/tbaa005. eCollection 2020 Apr. Antib Ther. 2020. PMID: 33928226 Free PMC article. Review.
-
Considerations for the Design of Antibody-Based Therapeutics.J Pharm Sci. 2020 Jan;109(1):74-103. doi: 10.1016/j.xphs.2019.05.031. Epub 2019 Jun 4. J Pharm Sci. 2020. PMID: 31173761 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials